JPMorgan cuts Leidos Holdings stock target from USD 160.00 to USD 142.00

Published on 10/17/2026 at 18:53 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Leidos reports on November 3, 2026. Leidos Holdings stock costs USD 124.85 on October 16, 2026 at 4:00 p.m. ET, up 0.69 percent on Nasdaq.

Analyst target and reporting date

JPMorgan cut its Leidos target from USD 160.00 to USD 142.00 on October 8, 2026.
Leidos scheduled its third-quarter results for November 3, 2026.
Leidos Holdings stock last traded at USD 124.85 on October 16, 2026, plus 0.69 percent versus the Nasdaq prior close.
Leidos had a P/E ratio of 11.65 and a market capitalization of USD 15.7 billion.

Isometrische 3D-Grafik der Prozesskette von Satellitendaten bis zur Missionssteuerung — Isometrische 3D-Grafik illustriert fuer Leidos Holdings ISIN US5253271028 die Kette von Satellitendaten bis Missionssteuerung, Illustration mit AI erstellt.

JPMorgan cut its Leidos Holdings target from USD 160.00 to USD 142.00 on October 8, 2026, leaving the stock with 13.70 percent upside to the new target from its USD 124.85 Nasdaq price. According to Investing.com, the bank also downgraded Leidos from Overweight to Neutral. Leidos Holdings stock last traded at USD 124.85 on Nasdaq on October 16, 2026 at 4:00 p.m. ET, plus 0.69 percent versus the prior close of October 15, 2026.

JPMorgan target sits above the price

The target change places JPMorgan's USD 142.00 valuation 13.70 percent above the latest Nasdaq price. The analyst action followed concerns about margin pressure in Leidos' Health business, while the report also pointed to potential growth in defense products and federal modernization work.

Results are scheduled for November 3

Leidos scheduled its third-quarter 2026 results and conference call for November 3, 2026, at 8:00 a.m. ET. The company said the release will cover the period ending October 2, 2026, according to Leidos. That date gives investors the next scheduled test of the outlook behind the recent target revisions.

Stock remains below its yearly high

Leidos traded 39.33 percent below its 52-week high of USD 205.77 and 26.28 percent above its 52-week low of USD 98.86, with both levels measured on October 16, 2026. Volume was 1,246,946 shares against an average of 1,336,140 shares on that date. The company is listed on the NYSE under ticker LDOS.

Valuation and peer comparison

Leidos had a market capitalization of USD 15.7 billion and a P/E ratio of 11.65 as of October 16, 2026. Its market value was larger than Booz Allen Hamilton's USD 8.9 billion but smaller than the two companies' combined market value, while its P/E was nearly identical to Booz Allen Hamilton's 11.64 and below Science Applications International's 15.56.

Comparison with peers

Leidos Holdings (NYSE, USD): plus 0.69 percent, P/E 11.65, market capitalization USD 15.7 billion.

Booz Allen Hamilton (NYSE, USD): minus 0.32 percent, P/E 11.64, market capitalization USD 8.9 billion.

Science Applications International (NYSE, USD): minus 0.18 percent, P/E 15.56, market capitalization USD 5.6 billion.

What investors can measure next

The November 3, 2026 reporting date is the next concrete calendar point, while the JPMorgan target provides a dated valuation reference. The price remains 39.33 percent below the 52-week high, keeping the market position materially below its yearly peak.

Market context: Market report S&P 500.

More news and analyses on Leidos Holdings stock